Cargando…

Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer

Overexpression of insulin growth factor receptor type 1 (IGF-1R) is observed in many cancers. Antibody drug conjugates (ADCs) with PEGylated maytansine (PEG(6)-DM1) show promise in vitro. We developed PEG(6)-DM1 ADCs with low and high drug to antibody ratios (DAR) using an anti-IGF-1R antibody cixut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solomon, Viswas Raja, Alizadeh, Elahe, Bernhard, Wendy, Makhlouf, Amal, Hartimath, Siddesh V., Hill, Wayne, El-Sayed, Ayman, Barreto, Kris, Geyer, Clarence Ronald, Fonge, Humphrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596529/ https://www.ncbi.nlm.nih.gov/pubmed/33122707 http://dx.doi.org/10.1038/s41598-020-75279-z

Ejemplares similares

Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft
por: Hartimath, Siddesh V., et al.
Publicado: (2019)

(89)Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo
por: Alizadeh, Elahe, et al.
Publicado: (2021)

(89)Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I
por: Chekol, Rufael, et al.
Publicado: (2018)

Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
por: Bernhard, Wendy, et al.
Publicado: (2021)

A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system
por: Alam, Md. Kausar, et al.
Publicado: (2018)

Nimotuzumab Site-Specifically Labeled with (89)Zr and (225)Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers
por: Solomon, Viswas Raja, et al.
Publicado: (2020)

Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study
por: Sekar, Sathiya, et al.
Publicado: (2021)

Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments
por: Bernhard, Wendy, et al.
Publicado: (2019)

A (89)Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior
por: Hajdu, Istvan, et al.
Publicado: (2018)

Evaluation of antibody fragment properties for near-infrared fluorescence imaging of HER3-positive cancer xenografts
por: El-Sayed, Ayman, et al.
Publicado: (2018)

Near infrared fluorescence imaging of EGFR expression in vivo using IRDye800CW-nimotuzumab
por: Bernhard, Wendy, et al.
Publicado: (2017)

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
por: Qu, Xiao, et al.
Publicado: (2017)

Evaluation of nimotuzumab Fab(2) as an optical imaging agent in EGFR positive cancers
por: Bernhard, Wendy, et al.
Publicado: (2023)

Production and Semi-Automated Processing of (89)Zr Using a Commercially Available TRASIS MiniAiO Module
por: Gaja, Vijay, et al.
Publicado: (2020)

Cixutumumab reveals a critical role for IGF-1 in adipose and hepatic tissue remodelling during the development of diet-induced obesity
por: Imrie, Helen, et al.
Publicado: (2022)

Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
por: Naing, A, et al.
Publicado: (2013)

A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours
por: Wilky, B A, et al.
Publicado: (2015)

Correction to: Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
por: Chugh, R., et al.
Publicado: (2019)

Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs
por: Barreto, Kris, et al.
Publicado: (2019)

An Improved Synthesis of N-(4-[(18)F]Fluorobenzoyl)-Interleukin-2 for the Preclinical PET Imaging of Tumour-Infiltrating T-cells in CT26 and MC38 Colon Cancer Models
por: Khanapur, Shivashankar, et al.
Publicado: (2021)

Imaging Immune Cells Using Fc Domain Probes in Mouse Cancer Xenograft Models
por: Bernhard, Wendy, et al.
Publicado: (2022)

Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial
por: Stockton, Shannon, et al.
Publicado: (2023)

Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach
por: Viswas, Raja Solomon, et al.
Publicado: (2019)

Generation of synthetic antibody fragments with optimal complementarity determining region lengths for Notch-1 recognition
por: Maruthachalam, Bharathikumar Vellalore, et al.
Publicado: (2022)

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer
por: Wong, Risa L., et al.
Publicado: (2020)

No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
por: Peterse, Elisabeth F. P., et al.
Publicado: (2016)

Recent Advances in Silver Nanoparticles Containing Nanofibers for Chronic Wound Management
por: Sabarees, Govindaraj, et al.
Publicado: (2022)

Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates
por: Tikum, Anjong Florence, et al.
Publicado: (2022)

Imaging Adipose Tissue Browning using Mitochondrial Complex-I Tracer [(18)F]BCPP-EF
por: Goggi, Julian L., et al.
Publicado: (2022)

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson’s disease
por: Goggi, Julian L., et al.
Publicado: (2020)

Estrone-3-Sulphate, a Potential Novel Ligand for Targeting Breast Cancers
por: Banerjee, Nilasha, et al.
Publicado: (2013)

Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model
por: Hartimath, Siddesh V., et al.
Publicado: (2022)

Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer
por: Goggi, Julian L., et al.
Publicado: (2022)

Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy
por: Goggi, Julian L., et al.
Publicado: (2022)

Preclinical Screening for Retinopathy of Prematurity Risk Using IGF1 Levels at 3 Weeks Post-Partum
por: Pérez-Muñuzuri, Alejandro, et al.
Publicado: (2014)

The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma()
por: Heske, Christine M., et al.
Publicado: (2016)

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study
por: Hartimath, Siddesh V., et al.
Publicado: (2018)

Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
por: Goggi, Julian L., et al.
Publicado: (2021)

Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models
por: Awasthi, Niranjan, et al.
Publicado: (2016)

Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes
por: Assefa, Biruhalem, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_15icbb4upuej119sj2h5ht2fh5